Enrique Lores - 07 Dec 2024 Form 4 Insider Report for HP INC (HPQ)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
10 Dec 2024, 20:20:06 UTC
Prior SEC filing
22 Nov 2024
Next SEC filing
11 Dec 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Rick Hansen as Attorney-in-Fact for Enrique Lores

Key filing fact

Enrique Lores filed Form 4 for HP INC (HPQ) on 10 Dec 2024.

Key facts

  • This page summarizes Enrique Lores's Form 4 filing for HP INC (HPQ).
  • 8 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 10 Dec 2024, 20:20.

Change

  • Previous filing in this sequence was filed on 22 Nov 2024.
  • Current net transaction value: -$4,893,704.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HPQ transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+169,612
Change %
+541%
Price
$0.000000
Shares after
200,958
Date
07 Dec 2024
Ownership
Direct
HPQ transaction

Common Stock

Tax liability

Transaction value
$2,908,417
Shares
-80,343
Change %
-40%
Price
$36.20
Shares after
120,615
Date
07 Dec 2024
Ownership
Direct
Footnotes
F1
HPQ transaction

Common Stock

Options Exercise

Transaction value
$3,011,788
Shares
+105,751
Change %
+88%
Price
$28.48
Shares after
226,366
Date
09 Dec 2024
Ownership
Direct
HPQ transaction

Common Stock

Sale

Transaction value
$4,997,076
Shares
-137,094
Change %
-61%
Price
$36.45
Shares after
89,272
Date
09 Dec 2024
Ownership
Direct
Footnotes
F2, F3
HPQ holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
888,908
Date
07 Dec 2024
Ownership
By Limited Partnership
Footnotes
F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HPQ transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-44,345
Change %
-100%
Price
Shares after
0
Date
07 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
44,345
Exercise price
Footnotes
F5, F6
HPQ transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-64,333
Change %
-52%
Price
Shares after
60,042
Date
07 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
64,333
Exercise price
Footnotes
F5, F7
HPQ transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-60,934
Change %
-34%
Price
Shares after
118,891
Date
07 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
60,934
Exercise price
Footnotes
F5, F8
HPQ transaction Derivative

Performance Contingent Stock Options

Options Exercise

Transaction value
$0
Shares
-105,751
Change %
-25%
Price
$0.000000
Shares after
317,251
Date
09 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
105,751
Exercise price
$28.48
Footnotes
F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 9 footnotes

Footnote F1

Shares withheld by HP to satisfy tax withholding upon vesting.

Footnote F2

The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 6/10/2024.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.145-$36.755, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F4

Represents shares held by a limited partnership, which is ultimately controlled by the reporting person.

Footnote F5

Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.

Footnote F6

As previously reported, on 12/7/2021, the reporting person was granted 120,676 RSUs, 1/3 of which vest annually over 3 years on the anniversary of the grant date. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 4,119 vested dividend equivalent rights.

Footnote F7

As previously reported, on 12/8/2022, the reporting person was granted 180,126 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 4,291 vested dividend equivalent rights.

Footnote F8

As previously reported, on 12/19/2023, the reporting person was granted 178,336 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,489 vested dividend equivalent rights.

Footnote F9

On 12/8/2022, the reporting person was granted 634,503 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .